Elbert Tomáš, Hezký Petr, Jansa Petr
Institute of Organic Chemistry and Biochemistry of CAS, Flemingovo nám. 2, 16610, Prague 6, Czech Republic.
J Labelled Comp Radiopharm. 2016 Dec;59(14):615-618. doi: 10.1002/jlcr.3405. Epub 2016 May 19.
The radioactively labelled 6-amino-5-nitroso-uracil (1) and 5-acetyl-6-amino-1,3-dimethyl-uracil (2) were required for metabolic studies to assess their suitability as drug candidates. A common precursor for both compounds was [cyano- C]cyanoacetic acid (6), readily prepared from potassium [ C]cyanide. ACS reagents, namely, diethyl ether, acetic acid and acetic anhydride, had to be rigorously repurified to achieve a successful synthesis of C-labelled compounds on a tenth-of-a-milligramme scale. 6-Amino-5-nitroso-[6- C]uracil (1- C) (0.55 mCi) was prepared with radiochemical purity > 98% and specific activity (SA) = 55.6 mCi/mmol. 5-Acetyl-6-amino-1,3-dimethyl-[6- C]uracil (2- C) (8 mCi) was prepared with radiochemical purity > 97% and SA = 55.6 mCi/mmol. It has been shown that a SA assay can be made from standard C NMR spectra, thus avoiding the need to perform lengthier inverse-gated C NMR experiments.